Electronic Theses and Dissertations

Date of Award

1-1-2012

Document Type

Dissertation

Degree Name

Ph.D. in Pharmaceutical Sciences

Department

Biomolecular Sciences

First Advisor

Christopher R McCurdy

Second Advisor

David B. Murray

Third Advisor

John M. Rimoldi

Relational Format

dissertation/thesis

Abstract

Neuropeptide FF is an endogenous RF-amide with two receptor subtypes originally described as having anti-opioid characteristics. While peptide work helped to elucidate key features for targeting the subtypes of the neuropeptide FF receptor, non-peptide small molecules offer a more refined tool to discover features that affect selectivity and affinity. Improvements in small molecule ligands for neuropeptide FF support lead development and offer a clearer understanding of the binding pocket of each receptor subtype. Previous work on the lead 4–anilindopiperidine structure clarified a key feature between agonist and antagonist behavior. Early modifications of substituents of the piperidine nitrogen were tolerated and created selective ligands. Therefore, syntheses of aliphatic and aromatic substitutions of the piperidine nitrogen of a 4–anilinopiperdine lead molecule were conducted. In vitro evaluation of the novel compounds was conducted through a collaborator. Binding affinities of the novel compounds were determined through displacement of a radioligand ([3H]-NPVF for NPFF1 receptors and [3H]-EYF for NPFF2 receptors) and were conducted for each subtype. Though some of the compounds, such as cycloheptylmethyl substituted analog, did not bind within the limits of the assay to either subtype, other compounds, such as the cyclopropylmethyl and methylindole derivatives, did bind. The cyclopentylmethyl and methylindole derivatives offered a weak preference for the second subtype. The formalin assay offers an opportunity to evaluate neuropeptide FF in a tonic pain model. In summation, selective non-peptide ligands for each neuropeptide FF receptor offer a key tool to elucidating the evolving role of neuropeptide FF and creating potentially useful therapeutics in the future.

Concentration/Emphasis

Emphasis: Medicinal Chemistry

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.